Chandrasekhar Udata Selected Research

Chandrasekhar Udata Research Topics

2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 12/2019
1	Hypertension (High Blood Pressure) 01/2020
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Diarrhea 11/2018
1	Type 2 Diabetes Mellitus (MODY) 11/2018
1	Atherosclerosis 06/2009
1	Neoplasms (Cancer) 03/2004
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2004
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2004

2	monoclonal antibody RN168IBA 01/2020 - 12/2019
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Interleukin-7 Receptors (Interleukin 7 Receptor)IBA 01/2020
1	LDL Receptors (LDL Receptor)IBA 01/2020
1	ApolipoproteinsIBA 01/2020
1	Apolipoproteins B (ApoB)IBA 01/2020
1	Proprotein Convertase 9IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 01/2020
1	Interleukin-7 (Interleukin 7)IBA 12/2019
1	Glucagon Receptors (Glucagon Receptor)IBA 11/2018
1	Monoclonal AntibodiesIBA 11/2018
1	RN909IBA 11/2018
1	2- (2- chloro- 4- fluorobenzyl)- 3- (4- fluorophenyl)- 7- (trifluoromethyl)- 2H- indazoleIBA 06/2009
1	Adenosine Triphosphate (ATP)IBA 06/2009
1	CholesterolIBA 06/2009
1	LigandsIBA 06/2009
1	HydrazinesIBA 03/2004
1	DNA (Deoxyribonucleic Acid)IBA 03/2004
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2004
1	CalicheamicinsIBA 03/2004
1	Immunoconjugates (Immunoconjugate)IBA 03/2004
1	Inotuzumab OzogamicinIBA 03/2004
1	Gemtuzumab (Mylotarg)FDA Link 03/2004

1	Drug Therapy (Chemotherapy) 03/2004